After years of development, Isomorphic Labs says its AI-created drugs are nearly ready for human trials. Isomorphic Labs, the ...

Isomorphic Labs is preparing to test AI-designed drugs in humans, marking a new phase in drug development with artificial ...

Google DeepMind's Isomorphic Labs is preparing for human trials of AI-designed drugs, marking a significant advancement in ...

Google DeepMind's drug discovery company, Isomorphic Labs, is gearing up to launch the human trials of its AI-designed drugs.

Google DeepMind researchers believe that by building for India's linguistic, economic, and cultural complexity, their work ...

One day we hope to be able to say — well, here’s a disease, and then click a button and out pops the design for a drug to ...

Traditionally, drug discovery relied heavily on trial and error, with long timelines and high costs. The introduction of ...

Scientists unite to warn that a critical window for monitoring AI reasoning may close forever as models learn to hide their thoughts.

Monitoring AI's train of thought is critical for improving AI safety and catching deception. But we're at risk of losing this ...

The biotechnology sector is hailing a major milestone as Isomorphic Labs, a startup incubated by Google DeepMind, prepares to enter human trials with a drug candidate designed using artificial ...

This AI system can analyze up to one million DNA letters at once, predicting how tiny changes in noncoding regions trigger ...

Google DeepMind's moonshot, Isomorphic Labs, is gearing up to launch its first ever human trial of AI-designed drugs. The ...